| 國立臺灣大學 |
2012 |
Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways
|
Chang, Ming-Cheng; Chen, Chi-An; Chen, Pao-Jen; Chiang, Ying-Cheng; Chen, Yu-Li; Mao, Tsui-Lien; Lin, Han-Wei; Chiang, Wen-Hsien Lin; Cheng, Wen-Fang; 鄭文芳; 陳祈安; 江盈澄; 毛翠蓮 |
| 臺大學術典藏 |
2018-09-10T09:15:37Z |
Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways
|
Chen, Yu-Li; Mao, Tsui-Lien; Mao, Tsui-Lien; Lin, Han-Wei; Lin, Han-Wei; Chiang, Wen-Hsien Lin; Cheng, Wen-Fang; Chang, Ming-Cheng;Chen, Chi-An;Chen, Pao-Jen;Chiang, Ying-Cheng;Chen, Yu-Li;Mao, Tsui-Lien;Lin, Han-Wei;Chiang, Wen-Hsien Lin;Cheng, Wen-Fang; Chang, M.-C. and Chen, C.-A. and Chen, P.-J. and Chiang, Y.-C. and Chen, Y.-L. and Mao, T.-L. and Lin, H.-W. and Lin Chiang, W.-H. and Cheng, W.-F.; Chang, Ming-Cheng;Chen, Chi-An;Chen, Pao-Jen;Chiang, Ying-Cheng;Chen, Yu-Li;Mao, Tsui-Lien;Lin, Han-Wei;Chiang, Wen-Hsien Lin;Cheng, Wen-Fang; 鄭文芳;陳祈安;江盈澄;毛翠蓮; 鄭文芳;陳祈安;江盈澄;毛翠蓮; Chang, Ming-Cheng; CHI-AN CHEN; WEN-FANG CHENG; Chen, Chi-An; Chen, Pao-Jen; Chiang, Ying-Cheng; Chiang, Ying-Cheng |
| 臺大學術典藏 |
2020-02-06T05:22:07Z |
Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways
|
WEN-FANG CHENG;Lin Chiang W.-H.;Lin H.-W.;Mao T.-L.;Chen Y.-L.;Chiang Y.-C.;Chen P.-J.;Chen C.-A.;Chang M.-C.; Chang M.-C.; Chen C.-A.; Chen P.-J.; Chiang Y.-C.; Chen Y.-L.; Mao T.-L.; Lin H.-W.; Lin Chiang W.-H.; WEN-FANG CHENG; Chang M.-C.; Chen C.-A.; Chen P.-J.; Chiang Y.-C.; Chen Y.-L.; Mao T.-L.; Lin H.-W.; Lin Chiang W.-H.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-14T02:49:55Z |
Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways
|
Chang M.-C.; Chen C.-A.; Chen P.-J.; Chiang Y.-C.; Chen Y.-L.; Mao T.-L.; Lin H.-W.; Lin Chiang W.-H.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-03-05T12:32:52Z |
Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways
|
Chang M.-C.; Chen C.-A.; Chen P.-J.; Chiang Y.-C.; Chen Y.-L.; TSUI-LIEN MAO; Lin H.-W.; Lin Chiang W.-H.; Cheng W.-F. |
| 國立臺灣大學 |
2009 |
Mesothelin Inhibits Paclitaxel-Induced Apoptosis through the Pi3k Pathway
|
陳祈安; 謝長堯; 李建南; 蘇怡寧; 鄭文芳; CHEN, CHI-AN; HSIEH, CHANG-YAO; LEE, CHIEN-NAN; SU, YI-NING; CHENG, WEN-FANG |
| 臺大學術典藏 |
2018-09-10T07:24:15Z |
Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway
|
Chang, M.-C. and Chen, C.-A. and Hsieh, C.-Y. and Lee, C.-N. and Su, Y.-N. and Hu, Y.-H. and Cheng, W.-F.; 陳祈安;謝長堯;李建南;蘇怡寧;鄭文芳; CHEN, CHI-AN;HSIEH, CHANG-YAO;LEE, CHIEN-NAN;SU, YI-NING;CHENG, WEN-FANG; CHI-AN CHEN; WEN-FANG CHENG; CHIEN-NAN LEE; CHEN, CHI-AN; HSIEH, CHANG-YAO; LEE, CHIEN-NAN; SU, YI-NING; CHENG, WEN-FANG |
| 臺大學術典藏 |
2020-01-22T07:50:42Z |
Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway
|
Chang M.-C.; CHI-AN CHEN; Hsieh C.-Y.; Lee C.-N.; Su Y.-N.; Hu Y.-H.; Cheng W.-F. |
| 臺大學術典藏 |
2020-02-06T05:22:15Z |
Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway
|
WEN-FANG CHENG;Hu Y.-H.;Su Y.-N.;Lee C.-N.;Hsieh C.-Y.;Chen C.-A.;Chang M.-C.; Chang M.-C.; Chen C.-A.; Hsieh C.-Y.; Lee C.-N.; Su Y.-N.; Hu Y.-H.; WEN-FANG CHENG; Chang M.-C.; Chen C.-A.; Hsieh C.-Y.; Lee C.-N.; Su Y.-N.; Hu Y.-H.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-12T04:06:03Z |
Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway
|
Cheng W.-F.; Hu Y.-H; Su Y.-N; CHIEN-NAN LEE; Hsieh C.-Y; Chang M.-C; Chen C.-A; Cheng W.-F.;Hu Y.-H;Su Y.-N;CHIEN-NAN LEE;Hsieh C.-Y;Chen C.-A;Chang M.-C |
| 臺大學術典藏 |
2009 |
Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway
|
Hu Y.-H.; WEN-FANG CHENG; Su Y.-N.; Lee C.-N.; Hsieh C.-Y.; Chen C.-A.; Chang M.-C. |
| 臺大學術典藏 |
2020-11-27T08:14:21Z |
Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway
|
Lee C.-N.; Su Y.-N.; Hu Y.-H.; Cheng W.-F.; Chang M.-C.; Chen C.-A.; CHANG-YAO HSIEH |
| 國立臺灣大學 |
2016 |
Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator
|
Chang, M-C; Chen, Y-L; Chiang, Y-C; Chen, T-C; Tang, Y-C; Chen, C-A; Sun, W-Z; Cheng, W-F; 鄭文芳; 孫維仁; 陳祈安; 江盈澄 |
| 臺大學術典藏 |
2018-09-10T15:39:08Z |
Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator
|
Chang, M.-C.; Chen, Y.-L.; Chiang, Y.-C.; Chen, T.-C.; Tang, Y.-C.; Chen, C.-A.; Sun, W.-Z.; Cheng, W.-F.; Chang, M.-C.; Chen, Y.-L.; Chiang, Y.-C.; Chen, T.-C.; Tang, Y.-C.; Chen, C.-A.; Sun, W.-Z.; Cheng, W.-F.; Cheng, W.-F. |
| 臺大學術典藏 |
2020-01-22T07:50:27Z |
Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator
|
Sun W.-Z.; Cheng W.-F.; CHI-AN CHEN; Tang Y.-C.; Chen T.-C.; Chiang Y.-C.; Chen Y.-L.; Chang M.-C. |
| 臺大學術典藏 |
2020-02-06T05:21:55Z |
Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator
|
WEN-FANG CHENG;Sun W.-Z.;Chen C.-A.;Tang Y.-C.;Chen T.-C.;Chiang Y.-C.;Chen Y.-L.;Chang M.-C.; Chang M.-C.; Chen Y.-L.; Chiang Y.-C.; Chen T.-C.; Tang Y.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG; Chang M.-C.; Chen Y.-L.; Chiang Y.-C.; Chen T.-C.; Tang Y.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-14T02:49:44Z |
Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator
|
Chang M.-C.;Chen Y.-L.;Chiang Y.-C.;Chen T.-C.;Tang Y.-C.;Chen C.-A.;Sun W.-Z.;Wen-Fang Cheng; Chang M.-C.; Chen Y.-L.; Chiang Y.-C.; Chen T.-C.; Tang Y.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-14T08:50:32Z |
Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator
|
Chang M.-C; Chen Y.-L; YING-CHENG CHIANG; Chen T.-C; Tang Y.-C; Chen C.-A; Sun W.-Z; Cheng W.-F. |
| 臺大學術典藏 |
2020-05-24T06:00:18Z |
Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator
|
Chang M.-C.; YU-LI CHEN; Chiang Y.-C.; Chen T.-C.; Tang Y.-C.; Chen C.-A.; Sun W.-Z.; Cheng W.-F. |
| 臺大學術典藏 |
2021-02-04T02:39:54Z |
Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator
|
Chang M.-C.;Yu-Li Chen;Chiang Y.-C.;Chen T.-C.;Tang Y.-C.;Chen C.-A.;Sun W.-Z.;Cheng W.-F.; Chang M.-C.; YU-LI CHEN; Chiang Y.-C.; Chen T.-C.; Tang Y.-C.; Chen C.-A.; Sun W.-Z.; Cheng W.-F. |
| 國立臺灣大學 |
2007 |
Mesothelin與上皮性卵巢癌病人其化學治療反應的關聯性
|
黃家彥; Huang, Chia-Yen |
| 臺大學術典藏 |
2003 |
Mesozoic high-Ba–Sr granitoids from North China: geochemical characteristics and geological implications
|
Qian, Qing; Chung, Sun-Lin; Lee, Tung-Yi; Wen, Da-Jen; Qian, Qing; Chung, Sun-Lin; Lee, Tung-Yi; Wen, Da-Jen |
| 國立臺灣大學 |
2003 |
Mesozoic high-Ba–Sr granitoids from North China: geochemical characteristics and geological implications
|
Qian, Qing; Chung, Sun-Lin; Lee, Tung-Yi; Wen, Da-Jen |
| 臺大學術典藏 |
2021-07-17T00:58:09Z |
Mesozoic juvenile crustal formation in the easternmost tethys: Zircon Hf isotopic evidence from Sumatran granitoids, Indonesia
|
Li S;Chung S.-L;Lai Y.-M;Ghani A.A;Lee H.-Y;Murtadha S.; Li S; Chung S.-L; Lai Y.-M; Ghani A.A; Lee H.-Y; Murtadha S.; SUN-LIN CHUNG |
| 國立臺灣大學 |
2001 |
Mesozoic shoshonitic intrusives in the Yangchun Basin, western Guangdong, and their tectonic significance: II. Trace elements and Sr-Nd isotopes
|
Li, X.H.; Zhou, H.W.; Liu, Y.; Lee, C.Y.; Chen, C-H.; Yu, J.S.; Gui, X.T. |
